Skip to main content

Origin Materials, Inc. (ORGN) Stock Forecast

Data as of Jun 16, 2026

Basic Materials · Current price $1.06 (-7.42%)

Consensus Target
$90.00
Upside
+8008.1%
Analysts
Rating

Price Target Range

Low $90.00High $90.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Aug 16, 2024Steve ByrneBank of America Securities$90.00+8390.6%

ORGN vs Sector & Market

MetricORGNBasic Materials AvgLarge Cap Avg
Analyst Rating2.372.40
Analyst Count719
Target Upside+8008.1%+50.9%+17.1%
P/E Ratio-1527.26-4.2931.64

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$112M$112M$112M1
2027-12-31$117M$117M$117M1
2028-12-31$225M$225M$225M1

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-9.30$-9.30$-9.301
2027-12-31$-2.70$-2.70$-2.701
2028-12-31$-0.90$-0.90$-0.901

Frequently Asked Questions

What is the analyst consensus for ORGN?

The consensus among 0 analysts covering Origin Materials, Inc. (ORGN) is — with an average price target of $90.00.

What is the highest price target for ORGN?

The highest price target for ORGN is $90.00, set by Steve Byrne at Bank of America Securities on 2024-08-16.

What is the lowest price target for ORGN?

The lowest price target for ORGN is $90.00, set by Steve Byrne at Bank of America Securities on 2024-08-16.

How many analysts cover ORGN?

0 analysts have issued ratings for Origin Materials, Inc. in the past 12 months.

Is ORGN a buy or sell right now?

Based on 0 analyst ratings, ORGN has a consensus rating of — with a +8008.1% upside to the consensus target of $90.00.

What are the earnings estimates for ORGN?

Analysts estimate ORGN will report EPS of $-9.30 for the period ending 2026-12-31, with revenue estimated at $112M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.